Janux Therapeutics, Inc. (JANX) Financials
JANX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 386.9 million | 37.9 million |
2023-06-30 | 341.5 million | 42.0 million |
2023-03-31 | 353.0 million | 41.7 million |
2022-12-31 | 364.0 million | 43.3 million |
JANX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -12.2 million | 4.5 million |
2023-06-30 | -15.6 million | 5.5 million |
2023-03-31 | -14.2 million | 5.5 million |
2022-12-31 | -14.0 million | 4.2 million |
JANX Net Income
No data available :(
JANX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 349.7 million | - | 24.9 million |
2023-06-30 | 303.3 million | - | 25.2 million |
2023-03-31 | 316.9 million | - | 25.5 million |
2022-12-31 | 327.0 million | - | 25.3 million |
JANX Shares Outstanding
JANX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 470000 | 11.9 million | 6.4 million | - |
2023-06-30 | 580000 | 14.9 million | 6.9 million | - |
2023-03-31 | 285000 | 15.9 million | 6.5 million | - |
2022-12-31 | 2.1 million | 15.4 million | 5.7 million | - |
JANX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 2.5 million | 500000 |
2023-06-30 | 1.1 million | 471000 |
2023-03-31 | 2.0 million | 453000 |
2022-12-31 | 2.8 million | 403000 |
JANX
Price: $64.78
52 week price:
Earnings Per Share: -1.32 USD
P/E Ratio: -5.66
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 219876
Market Capitalization: 2.1 billion